BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lieder HR, Braczko F, Gedik N, Stroetges M, Heusch G, Kleinbongard P. Cardioprotection by post-conditioning with exogenous triiodothyronine in isolated perfused rat hearts and isolated adult rat cardiomyocytes. Basic Res Cardiol 2021;116:27. [PMID: 33876304 DOI: 10.1007/s00395-021-00868-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Tu F, Yu G, Wu W, Xiang J, Wei Z, Liu Q, Lin X. Triiodothyronine enhances cardiac contractility in septic rats and probably through Akt-Caspase9 pathway to reduce septic-induced cardiomyocyte apoptosis. Mol Cell Probes 2022;66:101852. [PMID: 36084907 DOI: 10.1016/j.mcp.2022.101852] [Reference Citation Analysis]
2 Mourouzis I, Apostolaki V, Trikas A, Kokkinos L, Alexandrou N, Avdikou M, Giannoulopoulou M, Vassi A, Tseti I, Pantos C. The Potential of Thyroid Hormone Therapy in Severe COVID-19: Rationale and Preliminary Evidence. IJERPH 2022;19:8063. [DOI: 10.3390/ijerph19138063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kleinbongard P, Kuthan P, Eickelmann C, Jakobs P, Altschmied J, Haendeler J, Ruhparwar A, Thielmann M, Heusch G. Triiodothyronine improves contractile recovery of human atrial trabeculae after hypoxia/reoxygenation. Int J Cardiol 2022:S0167-5273(22)00949-4. [PMID: 35728699 DOI: 10.1016/j.ijcard.2022.06.050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Bogush N, Tan L, Naqvi E, Calvert JW, Graham RM, Taylor WR, Naqvi N, Husain A. Remuscularization with triiodothyronine and β1-blocker therapy reverses post-ischemic left ventricular dysfunction and adverse remodeling. Sci Rep 2022;12:8852. [PMID: 35614155 DOI: 10.1038/s41598-022-12723-2] [Reference Citation Analysis]
5 Raphael Lieder H, Tsoumani M, Andreadou I, Schrör K, Heusch G, Kleinbongard P. Platelet-Mediated Transfer of Cardioprotection by Remote Ischemic Conditioning and Its Abrogation by Aspirin But Not by Ticagrelor. Cardiovasc Drugs Ther 2022. [PMID: 35595877 DOI: 10.1007/s10557-022-07345-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
6 Khalifa AA, El Sokkary NH, Elblehi SS, Diab MA, Ali MA. Potential cardioprotective effect of octreotide via NOXs mitigation, mitochondrial biogenesis and MAPK/Erk1/2/STAT3/NF-kβ pathway attenuation in isoproterenol-induced myocardial infarction in rats. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.174978] [Reference Citation Analysis]
7 Han Y, Li CF, Zhang PZ, Yang XQ, Min JX, Wu QH, Xie YY, Jin Z, Wang ZT, Shao F, Quan HX. Protective effects of 5(S)-5-carboxystrictosidine on myocardial ischemia-reperfusion injury through activation of mitochondrial KATP channels. Eur J Pharmacol 2022;:174811. [PMID: 35182546 DOI: 10.1016/j.ejphar.2022.174811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kornyushin O, Sonin D, Polozov A, Masley V, Bulavinova N, Chervyak M, Istomina M, Mukhametdinova D, Neimark A, Cheburkin Y, Toropova Y, Derkach K, Shpakov A, Galagudza M, Shlyakhto E. Effect of sleeve gastrectomy, Roux-en-Y gastric bypass, and ileal transposition on myocardial ischaemia-reperfusion injury in non-obese non-diabetic rats. Sci Rep 2021;11:23888. [PMID: 34903800 DOI: 10.1038/s41598-021-03283-y] [Reference Citation Analysis]
9 Gurevich KG, Urakov AL, Fisher EL, Abzalilov TA, Khairzamanova KA, Yagudin TA, Samorodov AV. Possibilities of pharmacological correction of reperfusion injury of ischemic myocardium (review). Rev Clin Pharm Drug Ther 2021;19:259-267. [DOI: 10.17816/rcf193259-267] [Reference Citation Analysis]